Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

T Rowe Price Funds SICAV - European Structured Research Equity Fund

+ Add to Watchlist

TRPESRI:LX

20.25 EUR 0.20 1.00%

As of 00:59:30 ET on 03/27/2015.

Snapshot for T Rowe Price Funds SICAV - European Structured Research Equity Fund (TRPESRI)

Year To Date: +16.38% 3-Month: +15.85% 3-Year: +15.16% 52-Week Range: 15.75 - 20.57
1-Month: +1.61% 1-Year: +22.50% 5-Year: +10.96% Beta vs MXEU: 0.96

Mutual Fund Chart for TRPESRI

No chart data available.
  • TRPESRI:LX 20.25
  • 1M
  • 1Y
Interactive TRPESRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TRPESRI

T Rowe Price Funds SICAV- European Structured Research Equity Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to provide long-term capital appreciation through investment in primarily transferable securities and Equity related securities.

Inception Date: 01-07-2005 Telephone: 352-27-47-251 Tel
Managers: ANN HOLCOMB / KAMRAN BAIG
Web Site: www.troweprice.com/institutional

Fundamentals for TRPESRI

NAV (on 2015-03-27) 20.25
Assets (M) (on 2015-03-27) 7.60
Fund Leveraged N
Minimum Investment 2,500,000.00
Minimum Subsequent Investment 100,000.00

Dividends for TRPESRI

No dividends reported

Fees & Expenses for TRPESRI

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.65

Top Fund Holdings for TRPESRI

Filing Date: 12/31/2014
Name Position Value % of Total
Novartis AG 2,973 228,349 3.499%
Nestle SA 3,202 194,274 2.977%
Royal Dutch Shell PLC 6,175 170,619 2.615%
Bayer AG 1,232 139,216 2.133%
GlaxoSmithKline PLC 7,250 127,997 1.962%
Roche Holding AG 542 121,666 1.865%
HSBC Holdings PLC 14,543 113,561 1.740%
Vodafone Group PLC 36,674 104,767 1.606%
Barclays PLC 30,936 96,651 1.481%
BNP Paribas SA 1,741 85,762 1.314%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil